ClinicalTrials.gg
RecruitingNCT07932977PORTIONS_V_RCTUpdated Nov 12, 2026

Comprehensive Intervention for Changing Eating Habits Through Portion Control

An interventional study of Portion control and Healthy lifestyle in Lifestyle Intervention, Weight Management and Behaviour Change, sponsored by Clinica Universidad de Navarra, Universidad de Navarra. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Clinica Universidad de Navarra, Universidad de Navarra · Not applicable, Interventional, and Treatment

Updated Nov 12, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
181
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This is a 12-month randomized controlled trial designed to evaluate the effectiveness of a comprehensive self-applied lifestlye intervention for weight loss, based on portion control. A total of 181 volunteers with overweight/obesity will be randomly allocated to an experimental intervention group or an active control group. The experimental intervention will include 4 components: (1) a portion control toolset (eating utensils); (2) a manual including instructions for the use of the tools, dietary and activity recommendations, and behavioural strategies; (3) a mobile app to motivate intervention engagement; and (4) a recipe book to help integrate the intervention in daily life. The control group will receive standard guidelines for healthy living, including diet and physical activity. Both groups will attend 4 clinical investigation days, 2 group sessions and will receive periodic telephone support. The primary outcome will be the change in waist circumference from baseline, assessed at 3, 9 and 12 months. Other measurements will include body composition, fasting biochemical parameters, eating behaviour, gut microbiota, functional magnetic resonance, portion size norms, intervention adherence and acceptance. The study will test the hypothesis that a comprehensive intervention focused on portion control can promote changes in eating habits and reduce waist circumference over 12 months compared with receving standard healthy living advice (active control group).

Read the detailed description

Overweight and obesity are highly prevalent worldwide and represent major public health challenges. Nutritional interventions aimed at weight management frequently require sustained changes in eating behaviour, yet maintaining adherence to dietary recommendations over the long term remains challenging. Portion control represents a potentially useful strategy for promoting healthier eating habits, particularly through its potential effects on dietary energy density and meal composition. However, the mechanisms through which sustained changes in portion-related behaviours may influence body composition, metabolic health, eating behaviour and other physiological and cognitive processes remain insufficiently understood. Another challenge in nutritional intervention research is to assess dietary changes beyond their relationship with body weight alone. Changes in eating behaviour may be associated with metabolic markers, cognitive and behavioural processes, neural responses related to food intake, gut microbiota, and quality of life. A comprehensive assessment of these dimensions may therefore contribute to a better understanding of the factors associated with adherence to nutritional interventions and successful long-term weight management.

The primary objective of this randomized controlled trial is to confirm the effectiveness and long-term impact of a comprehensive weight management intervention focused on changing eating habits through portion control. The intervention is designed to facilitate the self-management of eating behaviour and promote sustained changes in the selection, composition and quantity of food consumed. The effect of the intervention will be assessed through changes in body composition at 3, 9 and 12 months, with change in waist circumference as the primary outcome. Secondary assessments will include metabolic, cognitive-behavioural and quality of life measures. The selection of these variables is informed by findings from the preceding PORTIONS-4 pilot study and by the scientific literature supporting the assessment of anthropometric and functional measures of adiposity in addition to weight and height-based indices such as body mass index (BMI), as well as comprehensive assessment of cognitive and behavioural factors, including habit formation, involved in eating and adherence.

The study will use a two-arm randomized controlled trial design, with participants allocated to either an experimental intervention group or a control group. A total of 181 participants will be enrolled, with 121 participants assigned to the experimental group and 60 to the control group. Participants allocated to the experimental group will receive a set of theoretical and practical strategies specifically developed or selected for this study to facilitate self-management of health and, in particular, the consumption of foods in recommended portions and quantities. The experimental intervention will consist of 4 complementary components: (1) an educational guide providing recommendations on nutrition, well-being and physical activity; (2) a toolset of optimized dietary tools consisting of a portion-serving spoon and a calibrated oil dispenser; (3) a recipe book specifically designed to provide healthy and sustainable recipes consistent with the intervention principles; and (4) a mobile application designed to support engagement with the intervention and facilitate the implementation of its recommendations in daily life. Participants allocated to the control group will receive an enhanced standard intervention based on theoretical nutrition education derived from recommendations provided by official health and nutrition organizations, together with recipes and physical activity guidelines. Both groups will participate in the intervention for 12 months, will receive six follow-up telephone calls throughout the intervention period and will receive the same degree of training and follow-up support, in order to minimize the potential influence of differences in contact level, education or support between groups.

The protocol includes clinical assessments at baseline and at 3, 9 and 12 months. Participants will also take part in two initial group sessions, two final group sessions and one central focus group (subsample) during the intervention period. At the scheduled clinical assessments, participants will undergo a comprehensive evaluation including biochemical measurements (glucose, insulin, lipid profile, ghrelin and glucagon-like peptide-1), body composition (assessed by bioelectrical impedance analysis) and physical function (handgrip strength assessment), psychological and quality-of-life questionnaires, eating rate and dietary composition. The study will also assess habit formation, food addiction, sensory and behavioural characteristics potentially related to eating behaviour, including taste detection thresholds. Changes in the gut microbiome will be evaluated to investigate potential biological adaptations associated with the intervention. In addition, functional magnetic resonance imaging will be used in a subsample to assess changes in neural activation and connectivity within networks involved in food-related processing and eating behaviour. These assessments will contribute to the investigation of potential interactions between eating behaviour, the gut microbiome and brain function during the weight management process.

The overall aim of these complementary assessments is to identify physiological, behavioural and cognitive mechanisms associated with adherence to and success of nutritional interventions for weight management. Understanding these mechanisms may contribute to the development of more personalized, effective and sustainable approaches to nutritional intervention. The primary hypothesis is that, compared with the control group, participants receiving the experimental intervention will show greater improvements in waist circumference and other measures of body composition over the 12-month intervention period. Improvements are also expected in BMI and fat mass. It is further hypothesized that participants in the experimental group will show greater improvements in dietary composition and in their ability to identify and apply appropriate portion sizes, reflected in healthier food choices and greater use of the portion-control strategies provided by the intervention. These effects are expected to be associated with greater utilization and adherence to the experimental intervention components. Compared with the control group, the experimental group is also expected to show more favourable changes in metabolic markers, cognitive and behavioural measures, and quality-of-life questionnaire scores over time. Finally, the study is expected to identify differences between groups in gut microbiota patterns and neural activation or connectivity associated with eating behaviour. Together, these findings may help clarify the physiological and cognitive mechanisms underlying adherence and response to comprehensive nutritional interventions for weight management.

02

Conditions studied

  • Lifestyle Intervention
  • Weight Management
  • Behaviour Change
  • Portion Size

Keywords

  • Portion size
  • Portion control
  • Portion control tool
  • Dietary energy density
  • Satiety
  • Appetite control
03

In context

Lead sponsor

Clinica Universidad de Navarra, Universidad de Navarra is the lead sponsor of 161 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • equal or above 27.5 kg/m2 (26.0 kg/m2 for those of Asian descent), or waist circumference above 84 cm (female) or above 90 cm (male)
  • Eating home-made meals at least 5 days a week
  • Physically and mentally fit as assessed by the study researcher
  • On-going pharmacological and hormonal treatment is accepted when this does not affect the study parameters (e.g., glucose response, appetite), and when the participant has been in a stable dose for at least 3 months
  • Agreeing to undergo all the study procedures and consume the study foods
  • Being able to attend in person on 4 clinical investigation days and 2 compulsory group sessions during working hours
  • Being able to understand and agree to sign the form

Exclusion criteria

Exclusion Criteria:

  • Being a regular smoker (i.e., smoking more than 4 cigarettes a month)
  • Being pregnant, breastfeeding or planning a pregnancy
  • Exceed the weekly alcohol consumption limit for the corresponding sex (more than 14 units in women and more than 20 units in men)
  • Having followed a meal plan for weight loss and/or muscle mass gain in the 3 months prior to the start of the study intervention
  • Experiencing a weight change greater than 5% in the last 3 months
  • History of relevant functional or structural anomalies of the digestive system, such as malformation, angiodysplasia, active peptic ulcer, chronic inflammatory or malabsorption disease, or history of intestinal or bariatric surgery
  • Suffering from any type of cancer, currently undergoing treatment for cancer, or when a period of at least 5 years has not elapsed since its eradication
  • On-going chronic metabolic disease or obesity-related disease, or any systemic intestinal, liver or kidney disease such as type 1 or type 2 diabetes, severe dyslipidemia, uncontrolled thyroid function disorder, cirrhosis, inflammatory bowel disease, untreated anemia, etc. (will not be excluded due to "fatty liver")
  • Active mental health conditions, including dementia, that could interfere with the participant's ability to adequately follow the study protocol, or current use of psychiatric medications that may affect appetite (e.g., antidepressants). For stable-dose participants, cases will be evaluted on a one-to-one basis with the study medical team.
  • Engaging in 10 or more hours of vigorous physical activity per week.
  • Being allergic, or being intolerant to the study foods or their ingredients (regular or lactose-free yogurt and granola)
  • History of anaphylactic reaction to any food
  • Taking nutritional supplements as a prescription medication that may affect the results of the study
  • Taking over-the-counter nutritional supplements (that is, without a medical prescription) that may affect the results of the study, unless the person is willing to stop it during the 12 months of the study duration and only when a minimum of 14 days can be guaranteed prior to the basal measurements being taken
  • A high incidence of attitudes and behaviors associated with eating disorders, expressed as a score greater than 20 on the 26-item Eating Attitudes Test scale (EAT - 26)
  • Co-inhabiting with a study participant
  • Previous participation in PORTIONS-3 (preclinical study) or PORTIONS-4 (pilot trial)
  • For the body composition analysis, wearing a pacemaker or certain metallic implants.

ADDITIONAL EXCLUSION CRITERIA FOR SUB-STUDIES

Functional MRI sub-study - Additional Exclusion Criteria:

  • Claustrophobia
  • Presence of metallic implants, pacemakers, defibrillators, or other devices incompatible with functional magnetic resonance imaging (fMRI)
  • Body weight greater than 180 kg
  • Neck circumference greater than 62.8 cm
  • Any to undergoing magnetic resonance imaging identified through the MRI safety screening questionnaire
  • A score of 50% or lower for four or more of the food items included in the auditory stimuli in the food liking questionnaire, indicating insufficient familiarity with the stimuli
  • Allocation to the trial's focus group discussions, unless the participant explicitly expresses a willingness to participate in both the fMRI assessment and the focus group discussions

Gut microbiota sub-study - Additional Exclusion Criteria

During the 15 days preceding stool sample collection:

  • Use of antibiotics
  • Use of fiber supplements
  • Use of supplements that may affect the gut microbiota, such as probiotics or biotin
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Washout period

A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
181 participants (estimated)

Study arms

  • Experimental
    Experimental intervention arm

    Participants will receive a comprehensive 12-month intervention focused on changing eating habits through portion control. The intervention will include four components to promote lifestyle modification: (1) an educational guide with recommendations on nutrition, well-being and physical activity; (2) a portion-control toolset (calibrated oil dispenser and portion control serving spoon); (3) a healthy and sustainable recipe book; and (4) a mobile application to foster engagement with the intervention. Participants will also receive 6 follow-up telephone calls during the intervention period and will attend 4 clinical investigation days and 2 group sessions (with an additional 2 optional group sessions). A subsample of participants will undergo a focus group session (n=30) or functional magnetic resonance imaging (n=20).

    Behavioral: Portion control

  • Active comparator
    Active control group

    Participants will receive a 12-month enhanced standard intervention based on printed nutrition and physical activity recommendations/guidelines from official health and nutrition organizations (i.e., WHO). The intervention will include general dietary advice, recipes and physical activity guidelines. Participants will also receive 6 follow-up telephone calls during the intervention period and will attend 4 clinical investigation days and 2 group sessions (with an additional 2 optional group sessions). A subsample of participants will undergo a focus group session (n=15) or functional magnetic resonance imaging (n=10).

    Behavioral: Healthy lifestyle

Interventions

  • BehavioralPortion control

    Self-applied, multicomponent intervention with a previously validated portion control toolset

    Also known as: Lifestyle modification, Behaviour change

  • BehavioralHealthy lifestyle

    Active comparator with same level of follow-up as experimental group

    Also known as: Behaviour change

06

What researchers measure

Primary outcomes

  1. Change in Waist Circumference From Baseline

    Change in waist circumference (cm) from baseline will be assessed over the 12-month intervention period. Waist circumference will be measured using standardized anthropometric procedures

    Time frame: Week -1, Week 0, Week 12, Week 36, Week 48

Secondary outcomes

  1. Change from baseline in dietary energy density (kcal/g)

    Dietary energy (in kcal) and Dietary volume (in g) will be combined to obtain Dietary energy density (kcal/g).

    Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  2. Change from baseline in dietary nutrient composition (in g)

    Dietary nutrient composition (in g) will be defined as the average % energy provided by macronutrients, obtained from the 24 h dietary record

    Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  3. Change from baseline in dietary nutrient composition (in % energy)

    Dietary nutrient composition (in % energy) will be defined as the average % energy provided by macronutrients, obtained from the 24 h dietary record

    Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  4. Use of serving spoon (24 h frequency)

    Number of times the intervention spoon has been used in a period of 24 h (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  5. Use of oil dispenser (24 h frequency)

    Number of times the oil dispenser has been used in a period of 24 h (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  6. Use of intervention guide (24 h frequency)

    Number of times the intervention guide has been used in a period of 24 h

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  7. Use of intervention app (24 h frequency)

    Number of times the intervention app has been used in a period of 24 h (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  8. Use of cookbook (24 h frequency)

    Number of times the cookbook has been used in a period of 24 h

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  9. Use of serving spoon (15 day frequency)

    Number of times the intervention spoon has been used in a period of 15 days (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  10. Use of oil dispenser (15 day frequency)

    Number of times the oil dispenser has been used in a period of 15 days (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  11. Use of intervention guide (15 day frequency)

    Number of times the intervention guide has been used in a period of 15 days

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  12. Use of intervention app (15 day frequency)

    Number of times the intervention app has been used in a period of 15 days (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  13. Use of cookbook (15 day frequency)

    Number of times the cookbook has been used in a period of 15 days

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  14. Anthropometric profile: Body Height

    Height will be measured in m using a stadiometer

    Time frame: Week -1

  15. Anthropometric profile: Body Weight

    Weight will be measured in kg using Tanita scales

    Time frame: Week -1, Week 0

  16. Anthropometric profile: Waist Circumference

    Waist circumference will be measured in cm using a measuring tape

    Time frame: Week -1

  17. Anthropometric profile: Hip Circumference

    Hip circumference will be measured in cm using a measuring tape

    Time frame: Week -1

  18. Anthropometric profile: Neck Circumference

    Neck circumference will be measured in cm using a measuring tape

    Time frame: Week -1

  19. Anthropometric profile: Change from baseline in Body Weight

    Weight will be measured in kg

    Time frame: Week 12, Week 36, Week 48

  20. Anthropometric profile: Change from baseline in Body Mass Index

    Body Mass Index will be calculated from weight and height as kg/m\^2

    Time frame: Week 12, Week 36, Week 48

  21. Anthropometric profile: Change from baseline in Waist to Hip Ratio

    Waist to hip ratio is defined as the ratio of the waist circumference (cm) to the hip circumference (cm)

    Time frame: Week 12, Week 36, Week 48

  22. Anthropometric profile: Change from baseline in body fat composition

    Body fat composition will be quantified as fat mass (in kg, %) from a body composition analyser

    Time frame: Week 0, Week 12, Week 36, Week 48

  23. Biochemical profile: Change from baseline in fasting blood glucose

    Fasting blood glucose levels (mg/dL)

    Time frame: Week 0, Week 12, Week 36, Week 48

  24. Biochemical profile: Change from baseline in fasting insulin

    Fasting blood insulin levels (mIU/L)

    Time frame: Week 0, Week 12, Week 36, Week 48

  25. Biochemical profile: Change from baseline in fasting blood triglycerides

    Fasting blood triglycerides levels (mg/dL)

    Time frame: Week 0, Week 12, Week 36, Week 48

  26. Biochemical profile: Change from baseline in fasting blood total cholesterol

    Fasting blood total cholesterol levels (mg/dL)

    Time frame: Week 0, Week 12, Week 36, Week 48

  27. Biochemical profile: Change from baseline in fasting blood HDL-cholesterol

    Fasting blood HDL-cholesterol levels (mg/dL)

    Time frame: Week 0, Week 12, Week 36, Week 48

  28. Biochemical profile: Change from baseline in fasting blood LDL-cholesterol

    Fasting blood LDL- cholesterol levels (mg/dL)

    Time frame: Week 0, Week 12, Week 36, Week 48

  29. Biochemical profile: Change from baseline in fasting blood ghrelin

    Fasting blood ghrelin levels (pg/mL)

    Time frame: Week 0, Week 12, Week 36, Week 48

  30. Biochemical profile: Change from baseline in fasting blood leptin

    Fasting blood leptin levels (ng/mL)

    Time frame: Week 0, Week 12, Week 36, Week 48

  31. Biochemical profile: Change from baseline in fasting blood GLP-1

    Fasting blood GLP-1 levels (pmol/mL)

    Time frame: Week 0, Week 12, Week 36, Week 48

  32. Meal eating behaviour: Change from baseline in Eating rate

    Average amount of yogurt with granola consumed per unit of time (g/min), based on validated methodology (Yeomans, 2000)

    Time frame: Week 0, Week 12, Week 36, Week 48

  33. Meal eating behaviour: Change from baseline in Bite Size

    Average amount of yogurt with granola consumed at each bite (g), based on validated methodology (Yeomans, 2000)

    Time frame: Week 0, Week 12, Week 36, Week 48

  34. Meal eating behaviour: Change from baseline in Meal Duration

    Average time used to eat a yogurt with granola (min), based on validated methodology (Yeomans, 2000)

    Time frame: Week 0, Week 12, Week 36, Week 48

  35. Meal eating behaviour: Change from baseline in Deceleration Rate

    Average change in eating rate (g/sec-squared), based on validated methodology (Yeomans, 2000)

    Time frame: Week 0, Week 12, Week 36, Week 48

  36. Learning task: Change from baseline in learned meal portion size

    % error in chosen portion sizes for starch, protein and vegetables of a virtual meal vs recommended portion sizes (based on Brunstrom \& Rogers, 2009)

    Time frame: Week 0, Week 12, Week 36, Week 48

  37. Learning task: Change from baseline in learned meal nutrient content

    % error in chosen nutrient content of a virtual meal vs recommended nutrient content (based on Brunstrom \& Rogers, 2009)

    Time frame: Week 0, Week 12, Week 36, Week 48

  38. Neural Activity Related to Food Reward Processing

    Neural activity associated with food reward and eating- related sensations, assessed using functional magnetic resonance imaging (fMRI) during exposure to food-related auditory stimuli, based on Carnell et al., 2017 (Subsample n=30 only)

    Time frame: Week 0, Week 24, Week 48

  39. Gut Microbiota Diversity and Bacterial Abundance

    Gut microbiota diversity and abundance of bacterial taxa associated with metabolic status, adiposity, mental health, and eating behavior

    Time frame: Week 0, Week 48

  40. Food addiction

    Food addiction symptoms assessed using the Yale Food Addiction Scale (YFAS), validated by Granero et al., 2018

    Time frame: Week -1, Week 24, Week 48

  41. Habit Automaticity

    Automaticity of eating-related habits assessed using the Self-Report Behavioural Automaticity Index (SRBAI), validated by Gardner et al., 2012

    Time frame: Week 1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  42. Eating habits: Eating profile

    Individual profile defined by the combined Restraint (0-21 points), Disihnibition (0-16 points) and Susceptibilty to hunger (0-14 points) sub-scales scores of the Three Factor Eating Questionnaire (TFEQ), validated by Stunkard \& Messick, 1985. Restraint values above 11, disinhibition values above 8 and susceptibility to hunger values above 4 are considered worse outcomes (i.e. risk for development of obesity and other eating disorders)

    Time frame: Week 0, Week 12, Week 36, Week 48

  43. Dietary energy (kcal)

    Dietary energy (kcal) will be obtained from the 24 h dietary record

    Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  44. Dietary volume (in g)

    Dietary volume (g) will be obtained from the 24 h dietary record

    Time frame: Week -1, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

Other outcomes

  1. Handgrip strength

    Handgrip strength will be measured in kg using a dynamometer

    Time frame: Week 0, Week 12, Week 36, Week 48

  2. Eating habits: Risk of eating disorders

    Score in the Eating Attitudes Test-26 (EAT-26), ranging from 0-78 points, validated by Garner et al., 1982. Scores above 20 suggest a higher risk for presence of potential eating disorders

    Time frame: Week -1

  3. Physical activity level

    Score in the short-form International Physical Activity Questionnaire (IPAQ), expressed as metabolic equivalent of task (MET)-minutes per week (Craig et al., 2003). Higher MET minutes indicates higher levels of physical activity.

    Time frame: Week 0, Week 12, Week 36, Week 48

  4. Quality of Life (QoL)

    Score in the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire (The WHOQOL Group, 1998). Higher scores indicate a higher perception of quality of life.

    Time frame: Week 0, Week 12, Week 36, Week 48

  5. Eating habits: Frequency of homemade meals

    Frequency of consuming homemade meals via self-reported questionnaire

    Time frame: Week -1

  6. Eating habits: Frequency of take away meals

    Frequency of consuming take away meals via self-reported questionnaire

    Time frame: Week -1

  7. Eating habits: Meal prep and serving

    Responsible person for cooking at home, via self-reported questionnaire

    Time frame: Week -1

  8. Eating habits: Liking for the intervention food (yogurt with granola)

    Liking for the foods to be used in the intervention, via self-reported questionnaire (100 mm visual analogue scale)

    Time frame: Week -1, Week 0, Week 12, Week 36, Week 48

  9. Eating habits: Familiarity with the intervention food (yogurt with granola)

    Familiarity with the foods to be used in the intervention, via self-reported questionnaire (100 mm visual analogue scale)

    Time frame: Week 0, Week 12, Week 36, Week 48

  10. Eating habits: Beverage consumption habits

    Shortened version of the pre-piloted on-line Beverage Portion Size survey (Self-reported questionnaire assessing caloric beverage intake and awareness of beverage portion sizes) (Vargas-Alvarez et al., 2022)

    Time frame: Week 0

  11. Eating habits: Problem Eating Behaviour Questionnaire (PEBQ)

    Validated questionnaire (Carter \& Jansen, 2012) used to identify eating patterns associated with the risk for obesity. It consists of 25 items answered on a 5-Pt intensity scale. The information collected can be used qualitatively, to identify problematic behaviors, or quantitatively by adding the direct scores. Scores greater than 50 suggest a moderate to high frequency of behaviors associated with obesity

    Time frame: Week 0, Week 12, Week 36, Week 48

  12. Self-reported medical history

    Self-reported questionnaire based on previous studies (Almiron-Roig et al., 2023) asking about special dietary needs, pregnancy, lactation, menopause, history of eating disorders, history of mental illness, incompatible medical conditions (e.g., cancer, diabetes, memory loss), regular medication including nutritional and other supplements

    Time frame: Week -1

  13. Anthropometric profile: General body composition

    Fat mass distribution (trunk, arms, legs), fat-free mass (kg, %), fat-free mass distribution, visceral fat score, basal metabolic rate (kcal/day)

    Time frame: Week 0, Week 12, Week 36, Week 48

  14. Psychological profile: Personality

    Score in the NEO-Five Factor Inventory (NEO-FFI) 60 item validated questionnaire (Costa \& McCrae, 1989). The score for each central domain of normal personality defined by the Five-Factor Model of personality (neuroticism, extraversion, conscientiousness, agreeableness, and openness to experience) is calculated. A higher score on a scale assessing a certain personality domain indicates a stronger expression of traits associated with this particular domain

    Time frame: Week -1

  15. Psychological profile: Perceived stress

    Score in the Perceived Stress Scale-14 (PSS-14) validated questionnaire (Cohen et al., 1983). Scores ranging from 0 to 13 suggest low stress, scores ranging from 14 to 24 suggest moderate stress, and scores above 27 suggest high perceived stress

    Time frame: Week -1

  16. Psychological profile: Emotional intelligence

    Score in the Trait Meta-Mood Scale-24 (TMMS-24) validated questionnaire (Salovey et al., 1995). The score for three different dimensions of emotional intelligence are calculated. To obtain a score for each factor, items 1 to 8 are added for the emotional attention factor, items 9 to 16 for the emotional clarity factor, and items 17 to 24 for the emotional repair factor

    Time frame: Week -1

  17. Psychological profile: Mood

    Score in the Profile of Mood States (POMS) validated questionnaire (McNair et al., 1971). The score for six different dimensions of mood (tension, anger, fatigue, depression, confusion, and vigour) is calculated. A higher score on a scale assessing a certain mood dimension indicates a stronger expression of associated feelings. The resulting scores will range from -24 to 177, with lower scores indicative of people with more stable mood profiles

    Time frame: Week -1

  18. Attitude towards intervention: Intervention expectations

    Self-constructed scale evaluated with the sum of scores (1-10) for 5 items (based on Borkovec \& Nau, 1972). The 5 items include rating the intervention's logic, satisfaction, recommendability, expected usefulness, and the respondent's readiness to follow it. A higher score reflects a more positive expectation towards the upcoming intervention

    Time frame: Week 0

  19. Attitude towards intervention: Intervention opinion

    Self-constructed scale evaluated with the sum of scores (1-10) for 5 items (based on Nau \& Borkovec, 1972). The 5 items include rating the intervention's logic, satisfaction, recommendability, usefulness, and the respondent's readiness/intention to continue with it. A higher score reflects a more positive opinion towards the experienced intervention

    Time frame: Week 12, Week 36

  20. Attitude towards intervention: Dietetic tool acceptance (serving spoon, oil dispenser)

    Previously piloted questionnaire (Almiron-Roig et al., 2016) including 5-Pt Likert scores for portion tool attractiveness, fits within lifestyle, embarrassment, ease of use, perceived effectiveness and resistant to use. An average score of 1 or 2 indicates low acceptance, 3 neutral, and 4 or 5 high acceptance (experimental arm only)

    Time frame: Week 12, Week 36, Week 48

  21. Attitude towards intervention: Dietetic tool intention to use (serving spoon, oil dispenser)

    Single scale instrument measuring the level of intention to use each component from 0-100 on a 100 mm visual analogue scale (previously piloted questionnaire, Almiron-Roig et al., 2016) (experimental arm only)

    Time frame: Week 12, Week 36, Week 48

  22. Attitude towards intervention: Perceived app usability

    System Usability Scale (SUS) (based on Brooke, 1996). Includes ten 5-Pt Likert questions of which 5 items are scored positively (pleasant, easy to use, good functionality, quick to learn, safe), and 5 items are scored reversedly (complex, requires support, inconsistent, complicated to use, requires learning). A higher overall score indicates higher perceived usability (experimental arm only)

    Time frame: Week 12, Week 36, Week 48

  23. Attitude towards intervention: App intention to use

    Single scale instrument measuring the level of intention to use the intervention app from 0-100 on a 100 mm visual analogue scale (previously piloted questionnaire, Almiron-Roig et al., 2016) (experimental arm only)

    Time frame: Week 12, Week 36, Week 48

  24. Attitude towards intervention: Intervention guide assessment

    Self-constructed questionnaire including 20 items answered with a 5-Pt Likert scale. The first 10 items assess content of the guide (credibility, coherence, usefulness, applicability) and the second 10 items assess format (organisation, word choice and communication style). A score \<60 indicates poor assessment (the tool cannot be used in clinical practice as it stands); a score between 60-79 indicates the tool needs revision before implementation; a score of 80 or above indicates the tool is well rated by potential users and may be useful in clinical practice

    Time frame: Week 12

  25. Attitude towards intervention: Intervention guide intention to use

    Single scale instrument measuring the level of intention to use the intervention guide from 0-100 on a 100 mm visual analogue scale (previously piloted questionnaire, Almiron-Roig et al., 2016)

    Time frame: Week 12

  26. Attitude towards intervention: Cookbook assessment

    Self-constructed questionnaire including 6 items answered with a 5-Pt Likert scale. The items assess coherence, usefulness, applicability, contents, word choice and communication style. A score \<18 indicates poor assessment (the tool cannot be used in clinical practice as it stands); a score between 18-24 indicates the tool needs revision before implementation; a score of 24 or above indicates the tool is well rated by potential users and may be useful in clinical practice

    Time frame: Week 12

  27. Attitude towards intervention: Cookbook intention to use

    Single scale instrument measuring the level of intention to use the Cookbook from 0-100 on a 100 mm visual analogue scale (previously piloted questionnaire, Almiron-Roig et al., 2016)

    Time frame: Week 12

  28. Intervention component usage: serving spoon

    Monthly questionnaire asking about types of meals in which the serving spoons were most frequently used in the last 2 weeks (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  29. Intervention component usage: oil dispenser

    Monthly questionnaire asking about types of meals in which the oil dispenser was most frequently used in the last 2 weeks (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  30. Intervention component usage: intervention guide

    Monthly questionnaire asking about guide sections most frequently checked in the last 2 weeks

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  31. Intervention component usage: Cookbook

    Monthly questionnaire asking about cookbook sections most frequently checked in the last 2 weeks

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  32. Intervention component usage: intervention app

    Monthly questionnaire asking about app functions most frequently used in the last 2 weeks (experimental arm only)

    Time frame: Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 40, Week 44, Week 48

  33. Protocol compliance on clinical investigation days

    Self-constructed interview to verify participants' compliance with arrival time, physical activity and dietary requirements and any change in medication occurred prior to each clinical investigation day

    Time frame: Week 0, Week 12, Week 36, Week 48

  34. Taste detection

    Taste detection thresholds for bitter, sweet, sour, and salty tastes, assessed using paper taste strips impregnated with the corresponding taste stimuli

    Time frame: Week 3, Weeks 40 to 44

  35. Barriers to Intervention Adherence

    Qualitative information on barriers to adherence encountered after 6 months of intervention, and participants' proposed solutions or strategies to overcome these barriers, collected through focus group discussions (subsample only n=45)

    Time frame: Weeks 21 to 24

  36. End of Study Survey

    Self-constructed interview to assess participant's overall experience with the intervention at study end (items include previous tools/methods employed, satisfaction with intervention, consistency of use, barriers experienced and intention to continue using the components)

    Time frame: Week 48

  37. Adverse Events

    Adverse events are defined as any new unfavourable and unintended event that the participant has experienced during the course of the intervention or treatment. AE do not necessarily have a causal relationship with the intervention. Examples of AE may include: * Abnormal laboratory findings * Symptoms (e.g. gastro-intestinal discomfort, headache) * Disease * Worsening of existing symptoms Serious adverse events (SAE) are defined as any untoward medical occurrence that: * Results in death * Is life-threatening at the time of the event * Requires in-patient hospitalization as in extension of an already planned hospitalization or requiring a new (unplanned) hospitalization * Results in persistent or significant disability or incapacity * Is another important medical event

    Time frame: Week 6, Week 9, Week 12, Week 16, Week 20, Week 24, Week 28, Week 32, Week 36, Week 48, plus spontaneous contacts from participants

  38. Eating habits: Hunger levels

    Fasting scores for hunger measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)

    Time frame: Week 0, Week 12, Week 36, Week 48

  39. Eating habits: Fullness levels

    Fasting scores for fullness measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)

    Time frame: Week 0, Week 12, Week 36, Week 48

  40. Eating habits: Thirst levels

    Fasting scores for thirst measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)

    Time frame: Week 0, Week 12, Week 36, Week 48

  41. Eating habits: Desire to eat levels

    Fasting scores for desire to eat measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)

    Time frame: Week 0, Week 12, Week 36, Week 48

  42. Eating habits: Prospective intake levels

    Fasting scores for prospective intake measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)

    Time frame: Week 0, Week 12, Week 36, Week 48

  43. Eating habits: Nausea levels

    Fasting scores for nausea measured on a 100 mm visual analogue scale, taken before consumption of yogurt with granola (validated questionnaire based on Hill \& Blundell, 1982)

    Time frame: Week 0, Week 12, Week 36, Week 48

  44. Socio-demographic profile: Age

    Age will be recorded in self-reported age in years at recruitment point

    Time frame: Week -1

  45. Socio-demographic profile: Sex

    Sex will be recorded as self-reported sex assigned at birth (male, female)

    Time frame: Week -1

  46. Socio-demographic profile: Gender

    Gender will be recorded as self-identified gender with one of these options: man, women, other (describe if you wish), prefer not to say.

    Time frame: Week -1

  47. Socio-demographic profile: Education

    Education will be recorded as self-reported maximum education level achieved with one these options: without education; prmary education; secondary education; seconary vocational education; high vocational education; university degree; other (specify).

    Time frame: Week -1

  48. Socio-demographic profile: marital status

    Marital status will be recorded as self-reported status with one of these options: married, civil union, separated, divorced, widowed, single (never married), other (specify).

    Time frame: Week -1

  49. Socio-demographic profile: Country of birth

    Self-reported country of birth will be recorded using an open-ended question "country of birth"

    Time frame: Week -1

  50. Socio-demographic profile: Employment

    Employment will be recorded as self-reported professional situation with one of these open-ended questions: Current job (if you have); Last job (in case of retirement, permanent leave, unemployment, etc.); Without a current or past job

    Time frame: Week -1

  51. Socio-demographic profile: Smoking status

    Smoking status will be recorded as self-reported habits with one of these options: never smoked; ex-smoker (for more than 3 months); current smoker; occasional smoker (fewer than 4 cigarettes per month).

    Time frame: Week -1

  52. Socio-demographic profile: alcohol intake

    Alcohol intake will be recorded as self-reported weekly alcohol unit consumption (1 unit = can, glass or shot).

    Time frame: Week -1

07

Study locations

1 of 1 sites recruiting
  • University of Navarra, Centre for Nutrition Research
    Pamplona, Navarre 31008, Spain
    Recruiting
    • Eva Almiron-Roig, PhD · Contactealmiron@unav.es · 34948425600
    • Diego N Messina, PhD · Contactdmessinalom@unav.es · 34948425600
    • Elkin O Luis, PhD · Sub investigator
    • Verónica Aramendia, PhD · Sub investigator
    • Fermín Milagro, PhD · Sub investigator
08

References and documents

Publications

  • Vargas-Alvarez MA, Quiroz V, Martinez JA, Almiron-Roig E. Development and piloting of an on-line questionnaire to assess portion size knowledge and consumption habits of non-alcoholic beverages. Appetite. 2022 Feb;169:105555. doi:10.1016/j.appet.2021.105555
  • McNair DM, Lorr M, Droppleman LF. Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971
  • Costa PT Jr, McCrae RR. NEO PI/FFI manual supplement for use with the NEO Personality Inventory and the NEO Five-Factor Inventory. Odessa, FL: Psychological Assessment Resources; 1989.
  • Brooke J. SUS: a quick and dirty usability scale. In: Jordan PW, Thomas B, McClelland IL, Weerdmeester B, editors. Usability Evaluation in Industry. London: Taylor & Francis; 1996. p. 189-194
  • Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry. 1972 Dec;3(4):257-260. doi:10.1016/0005-7916(72)90045-6.
  • Yeomans MR. Rating changes over the course of meals: what do they tell us about motivation to eat? Neurosci Biobehav Rev. 2000 Mar;24(2):249-59. doi: 10.1016/s0149-7634(99)00078-0. PubMed 10714388 ↗
  • Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985;29(1):71-83. doi: 10.1016/0022-3999(85)90010-8. PubMed 3981480 ↗
  • Hill AJ, Blundell JE. Nutrients and behaviour: research strategies for the investigation of taste characteristics, food preferences, hunger sensations and eating patterns in man. J Psychiatr Res. 1982-1983;17(2):203-12. doi: 10.1016/0022-3956(82)90023-1. PubMed 6764938 ↗
  • Granero R, Jimenez-Murcia S, Gearhardt AN, Aguera Z, Aymami N, Gomez-Pena M, Lozano-Madrid M, Mallorqui-Bague N, Mestre-Bach G, Neto-Antao MI, Riesco N, Sanchez I, Steward T, Soriano-Mas C, Vintro-Alcaraz C, Menchon JM, Casanueva FF, Dieguez C, Fernandez-Aranda F. Validation of the Spanish Version of the Yale Food Addiction Scale 2.0 (YFAS 2.0) and Clinical Correlates in a Sample of Eating Disorder, Gambling Disorder, and Healthy Control Participants. Front Psychiatry. 2018 May 25;9:208. doi: 10.3389/fpsyt.2018.00208. eCollection 2018. PubMed 29887808 ↗
  • Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The eating attitudes test: psychometric features and clinical correlates. Psychol Med. 1982 Nov;12(4):871-8. doi: 10.1017/s0033291700049163. PubMed 6961471 ↗
  • Gardner B, Abraham C, Lally P, de Bruijn GJ. Towards parsimony in habit measurement: testing the convergent and predictive validity of an automaticity subscale of the Self-Report Habit Index. Int J Behav Nutr Phys Act. 2012 Aug 30;9:102. doi: 10.1186/1479-5868-9-102. PubMed 22935297 ↗
  • Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8. doi: 10.1017/s0033291798006667. PubMed 9626712 ↗
  • Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB. PubMed 12900694 ↗
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available. PubMed 6668417 ↗
  • Carter FA, Jansen A. Improving psychological treatment for obesity. Which eating behaviours should we target? Appetite. 2012 Jun;58(3):1063-9. doi: 10.1016/j.appet.2012.01.016. Epub 2012 Jan 25. PubMed 22306789 ↗
  • Carnell S, Benson L, Chang KV, Wang Z, Huo Y, Geliebter A, Peterson BS. Neural correlates of familial obesity risk and overweight in adolescence. Neuroimage. 2017 Oct 1;159:236-247. doi: 10.1016/j.neuroimage.2017.07.052. Epub 2017 Jul 25. PubMed 28754348 ↗
  • Brunstrom JM, Rogers PJ. How many calories are on our plate? Expected fullness, not liking, determines meal-size selection. Obesity (Silver Spring). 2009 Oct;17(10):1884-90. doi: 10.1038/oby.2009.201. Epub 2009 Jun 18. PubMed 19543204 ↗
  • Almiron-Roig E, Navas-Carretero S, Castelnuovo G, Kjolbaek L, Romo-Hualde A, Normand M, Maloney N, Hardman CA, Hodgkins CE, Moshoyiannis H, Finlayson G, Scott C, Raats MM, Harrold JA, Raben A, Halford JCG, Martinez JA. Impact of acute consumption of beverages containing plant-based or alternative sweetener blends on postprandial appetite, food intake, metabolism, and gastro-intestinal symptoms: Results of the SWEET beverages trial. Appetite. 2023 May 1;184:106515. doi: 10.1016/j.appet.2023.106515. Epub 2023 Feb 26. PubMed 36849009 ↗
  • Almiron-Roig E, Dominguez A, Vaughan D, Solis-Trapala I, Jebb SA. Acceptability and potential effectiveness of commercial portion control tools amongst people with obesity. Br J Nutr. 2016 Dec;116(11):1974-1983. doi: 10.1017/S0007114516004104. Epub 2016 Dec 15. PubMed 27976604 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Jan 2028, 15 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 12, 2026
StartEst.
Oct 15, 2026
Primary completionEst.
Jan 29, 2028
CompletionEst.
Feb 29, 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07932977
Collaborators
University of Navarra
Responsible party
Sponsor
First posted
Nov 12, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Jan 29, 2028 (estimated)
Completion
Feb 29, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Eva Almiron Roig, PhD
Contact
ealmiron@unav.es
34948425600 ext. 803316
Diego N Messina, PhD
Contact
dmessinalom@unav.es
34948425600 ext. 806346
Eva Almiron-Roig, PhD
principal investigator · University of Navarra

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion